SomaLogic, Inc. (SLGC): Price and Financial Metrics
SLGC Price/Volume Stats
Current price | $2.10 | 52-week high | $3.79 |
Prev. close | $2.20 | 52-week low | $1.73 |
Day low | $1.93 | Volume | 33,910,700 |
Day high | $2.31 | Avg. volume | 10,825,875 |
50-day MA | $2.41 | Dividend yield | N/A |
200-day MA | $2.44 | Market Cap | 394.95M |
SLGC Stock Price Chart Interactive Chart >
SomaLogic, Inc. (SLGC) Company Bio
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow-offrate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Its SomaScan's biomarker discoveries help in diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company's solutions also include SomaSignal tests, which are research use only tests for clinical trial applications. It serves research and clinical customers with a focus on pharmaceutical and biotechnology companies, and academic research institutions; and facilitates drug development, analysis of clinical trials, and new human biology insights by assessing protein-protein and protein-gene networks. The company was incorporated in 1999 and is headquartered in Boulder, Colorado.
SLGC Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | -14.98% |
3-year | -83.87% |
5-year | N/A |
YTD | -17.00% |
2023 | 0.80% |
2022 | -78.44% |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...